DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Ekstedt M, Franzén LE, Mathiesen UL, Kechagias S.
Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
Scand J Gastroenterol 2012;
47 (01) 108-115
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.